<DOC>
	<DOCNO>NCT00970528</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety acarbose comparison voglibose type 2 diabetic patient whose blood glucose level inadequately control insulin glargine alone combination metformin .</brief_summary>
	<brief_title>Glucose Reduction Early Acarbose Treatment Basal Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Voglibose</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Aged 1879 year Type 2 diabetes inadequately control insulin glargine alone combination metformin Diagnosed type 2 diabetes least 6 month prior screen Treated tolerable , stable dose insulin glargine and/or metformin least 3 month prior screen HbA1C &gt; 7.0 &lt; /= 10.0 % screen Type 1 diabetes patient Myocardial infarction , unstable angina coronary artery bypass surgery within previous 6 month Clinical evidence active liver disease , serum ALT AST 3 time upper limit normal ( ULN ) range Serum creatinine &gt; /= 1.5 mg/dl male , &gt; /= 1.4 mg/dl female Active proliferative diabetic retinopathy Any antidiabetic medication except insulin glargine metformin within 4 week prior study entry Gastrointestinal disease likely associate abnormal intestinal motility alter absorption nutrient ( e.g . gastroparesis , malabsorption syndrome , chronic diarrhea state , enteropathy , inflammatory bowel disease , partial intestinal obstruction , large hernia ) Galactose intolerance Pregnancy Delivery , abortion , lactation within less three cycle start treatment No use contraceptive childbearing age . Women childbearing potential must agree use adequate contraception ( barrier method birth control ) since sign informed consent form least 30 day last study drug administration . Hypersensitivity active substance gradient study drug ingredient Treatment medication include corticosteroid herb medication affect blood glucose level 3 month prior study entry Any disease condition opinion investigator may interfere completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Oral Hypoglycemic Agent</keyword>
</DOC>